![John F. Miller](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cargos activos de John F. Miller
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Lotus Tissue Repair, Inc.
![]() Lotus Tissue Repair, Inc. Pharmaceuticals: MajorHealth Technology Lotus Tissue Repair, Inc. develops dermatologic treatment technologies. Its solutions include a protein replacement therapy for the treatment of dystrophic epidermolysis bullosa, a group of genetic skin disease. The company was founded by Mei Chen, Mark P. de Souza, Philip R. Reilly, David Woodley and James W. Fordyce in 2011 and is headquartered in Lexington, MA. | Director/Miembro de la Junta | - | - |
Presidente | - | - | |
Treasurer | - | - |
Historial de carrera de John F. Miller
Antiguos cargos conocidos de John F. Miller.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Shire Human Genetic Therapies, Inc.
![]() Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Director/Miembro de la Junta | - | - |
Presidente | - | - | |
Treasurer | - | - | |
BAXALTA INC | Presidente | - | - |
Treasurer | - | - |
Estadísticas
Internacional
Estados Unidos | 4 |
Operativa
President | 3 |
Treasurer | 3 |
Director/Board Member | 2 |
Sectorial
Health Technology | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 3 |
---|---|
Baxalta, Inc.
![]() Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
Shire Human Genetic Therapies, Inc.
![]() Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Health Technology |
Lotus Tissue Repair, Inc.
![]() Lotus Tissue Repair, Inc. Pharmaceuticals: MajorHealth Technology Lotus Tissue Repair, Inc. develops dermatologic treatment technologies. Its solutions include a protein replacement therapy for the treatment of dystrophic epidermolysis bullosa, a group of genetic skin disease. The company was founded by Mei Chen, Mark P. de Souza, Philip R. Reilly, David Woodley and James W. Fordyce in 2011 and is headquartered in Lexington, MA. | Health Technology |
- Bolsa de valores
- Insiders
- John F. Miller
- Experiencia